Natera Acquires Foresight Diagnostics in $450 Million Deal
Transaction expands Natera’s solid tumor MRD capabilities and adds ultrasensitive phased variant technology with detection below 0.1 parts per million.
Read MorePosted by CLP Edit Staff | Dec 8, 2025 | Lymphoma |
Transaction expands Natera’s solid tumor MRD capabilities and adds ultrasensitive phased variant technology with detection below 0.1 parts per million.
Read MorePosted by CLP Edit Staff | Dec 4, 2025 | Hematology & Serology |
The 2026 clinical lab fee schedule sets payment for CPT code 81195 at $1,853.22, up from $1,263.53 in 2025.
Read MorePosted by CLP Edit Staff | Nov 26, 2025 | Accreditation |
The accreditation covers liver health diagnostics, including Hepatotrack, a molecular diagnostic liquid biopsy that is predictive of acute liver rejection post-liver transplant.
Read MorePosted by CLP Edit Staff | Nov 24, 2025 | Clinical Chemistry Analyzers |
The all-in-one diagnostic platform combines hematology, biochemistry, and immunoassay testing in a single run.
Read MorePosted by CLP Edit Staff | Nov 19, 2025 | Company News |
The association’s incoming CEO brings more than two decades of leadership experience in global health, nonprofit management, and the scientific community.
Read More